The Epigenetics of Exercise and Physical Activity in COPD
NCT ID: NCT03539042
Last Updated: 2018-05-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
50 participants
OBSERVATIONAL
2018-03-01
2021-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Physical Activity Promotion on Short and Long-term Outcomes in COPD
NCT02099799
Home-based Health Management of Chronic Obstructive Lung Disease (COPD) Patients
NCT02999685
Home Pulmonary Rehabilitation for COPD
NCT03480386
Muscle Metabolism and Oxygenation During Localized Fatigue-exercise in COPD
NCT01909544
Exercise in Health and Chronic Obstructive Pulmonary Disease
NCT02300064
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of COPD (defined as an FEV1/FVC\<0.7 or evidence of emphysema on radiologist's read of a chest CT obtained in the course of patient's usual care)
* Referral to and participation in the VA Boston Pulmonary Rehabilitation program
Exclusion Criteria
* Inability to ambulate \> 1 block
* Recent acute exacerbation of COPD (defined as new or increased dose of systemic steroids and/or antibiotics for pulmonary indications)
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
VA Boston Healthcare System
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Emily S. Wan
Physician and Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Emily S Wan, MD,MPH
Role: PRINCIPAL_INVESTIGATOR
VA Boston Healthcare System
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
VA Boston Healthcare System
Boston, Massachusetts, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
3013
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.